Avantor, Inc. (NYSE:AVTR) Receives $10.47 Consensus Price Target from Analysts

Avantor, Inc. (NYSE:AVTR) has earned a consensus recommendation of “Reduce” from the seventeen analysts that are covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $10.4688.

Several brokerages recently weighed in on AVTR. Barclays upped their target price on shares of Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, June 24th. UBS Group set a $8.00 target price on Avantor in a research note on Wednesday, June 24th. Citigroup decreased their price objective on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating for the company in a research note on Thursday, April 30th. Wall Street Zen raised Avantor from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. Finally, Royal Bank Of Canada initiated coverage on shares of Avantor in a research report on Thursday, May 14th. They set a “sector perform” rating and a $9.00 target price on the stock.

Insider Buying and Selling at Avantor

In related news, Director Gregory T. Lucier purchased 10,000 shares of the stock in a transaction dated Friday, May 8th. The shares were acquired at an average cost of $8.32 per share, with a total value of $83,200.00. Following the purchase, the director directly owned 60,000 shares in the company, valued at $499,200. This trade represents a 20.00% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Simon Dingemans acquired 25,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The stock was purchased at an average cost of $8.14 per share, with a total value of $203,500.00. Following the completion of the purchase, the director directly owned 25,000 shares in the company, valued at $203,500. This represents a ? increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.28% of the stock is owned by company insiders.

Institutional Trading of Avantor

Several institutional investors and hedge funds have recently made changes to their positions in AVTR. EverSource Wealth Advisors LLC boosted its holdings in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new position in Avantor during the second quarter worth about $32,000. Private Trust Co. NA lifted its position in Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after buying an additional 875 shares during the period. Osaic Holdings Inc. boosted its stake in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the last quarter. Finally, Los Angeles Capital Management LLC purchased a new stake in Avantor in the 4th quarter valued at about $32,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Stock Down 0.3%

AVTR stock opened at $10.29 on Monday. The firm has a market cap of $7.03 billion, a PE ratio of -12.71, a PEG ratio of 5.98 and a beta of 0.94. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.17 and a current ratio of 1.76. The firm’s 50 day moving average price is $8.87 and its 200-day moving average price is $9.45. Avantor has a one year low of $7.26 and a one year high of $15.93.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.54 billion. During the same period in the prior year, the firm posted $0.23 earnings per share. The firm’s quarterly revenue was up .0% on a year-over-year basis. On average, equities research analysts anticipate that Avantor will post 0.79 EPS for the current year.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.